The Insider’s Guide to Health Care AI Policy in 2025: Unique Needs, Evolving Approaches 

Claire is the Chief Executive Officer at the Alliance for Health Policy. She is a dynamic executive with more than 25 years of experience effectively engaging others to catalyze change in health care and health policy. 

Claire has served in leadership roles in associations, corporations,  consulting and communications firms, including GMMB, the Blue Cross Blue Shield Association, Fleishman Hillard, the Generic Pharmaceutical Association (now AAM), Avalere, Alexion Pharmaceuticals, and others. In these roles, she has managed effective educational and engagement campaigns, introduced new capabilities, products and services, established novel cross-functional teams, and successfully achieved gains in reputational status, growth and audience impact. 

In her career, she has worked for organizations across the spectrum in health care ranging from scientific discovery to public health to patient advocacy.  These include non-profits like the Robert Wood Johnson Foundation, The Bill and Melinda Gates Foundation, and National Health Council; medical leaders like the American Academy of Family Physicians, the International Society for Stem Cell Research and Mayo Clinic; and companies like Biogen, Cigna, and Siemens Health. 

Claire is a graduate of the University of Illinois at Champaign-Urbana, where she served a semester as a research assistant to a member of UK parliament, and a co-founder of the campus sketch comedy troupe. She also holds an MSc. with Distinction from the London School of Economics in Media and Communications, where her dissertation focused on the construct of public opinion within the halls of the U.S. Congress. Claire also served as an adjunct professor at Johns Hopkins University, teaching students in the Communications MA program. She is the mother of two children, a cancer survivor, and serves as a Director on the Fairfax Library Foundation Board.

Kev Coleman is recognized as one of the leading experts in healthcare AI policy. His work has been featured by Politico and Fierce Healthcare and has shaped industry discussions on the safety and regulation of healthcare AI. He speaks frequently on this topic, having participated at events such as The Asian Leadership Summit in Seoul, South Korea, as well as Politico’s 2025 Health Care Summit, where he presented his work during a panel discussion alongside Rep. Ami Bera (D-CA). His notable papers on AI include Generalization Uncertainty in AI-Enabled Medical Devices, Healthcare AI Regulation: Guidelines for Maintaining Public Safety and Innovation, and Lowering Health Care Costs Through AI. Mr. Coleman‘s career spans work as a successful technology startup executive to healthcare research, and the results of the latter have been cited in top newspapers and media across the country and referenced in congressional health reform discussions (both Democratic and Republican).

Jodi Daniel is a partner at Wilson Sonsini where she provides strategic, legal, and policy advice to healthcare providers and health plans that are bringing innovation into practice, and to health technology clients navigating the dynamic health regulatory environment. Jodi is a leader in digital health and health data policy. She was the founding director of the Office of Policy in the Office of the National Coordinator for Health IT (ONC) at HHS, where she led the agency’s federal advisory committees and established national health IT policy on privacy, security, consumer e-health, telehealth, and safety and oversight. Jodi developed ONC’s regulatory capacity, led the adoption of health IT standards and certification regulations, and advised CMS on health IT incentive programs. Prior to her ONC role, Jodi was a key drafter of the original HIPAA Privacy and Enforcement Rules and served as HHS’s first senior counsel for health IT. Jodi received a BA in Economics from Tufts University, an MPH from Johns Hopkins School of Public Health, and a JD from Georgetown University Law Center. She is currently Assistant Professor Adjunct at Yale Medical School and serves on the National Academy of Medicine AI Code of Conduct Steering Committee.

Monica Massaro serves as the Director of Government Relations and Public Policy at Hooper, Lundy & Bookman and also has the role of Co Chair of the Digital Health Task Force. Monica represents a variety of health care entities before federal agencies and Congress. She specializes in Medicare payment, alternative payment models, and digital health. Prior to her time consulting she worked for a health care trade association. She has her Masters in Public Policy from George Mason University specializing in health care policy.

Jared Augenstein is a senior managing director with Manatt Health, an interdisciplinary policy and business advisory practice of Manatt. He provides strategic business advice, policy design and analysis as well as project management to health care providers, health tech companies, state and local governments, foundations, life sciences companies, and other health care organizations. Jared’s primary areas of focus are advising private- and public-sector clients on health technology, telehealth, artificial and augmented intelligence, care model design and transformation, federal and state health policy trends, and provider markets.

Jared has extensive experience in the digital health space, regularly advising health systems, policymakers, innovators and investors on digital health and virtual care strategy, remote monitoring, AI, implementation, operations, and policy. Jared has published extensively on a range of topics related to digital transformation, telemedicine and health system strategy, including coauthorships with the American Medical Association, the Association of American Medical Colleges, the Commonwealth Fund, Health Affairs and others.

Representative engagements include advising many of the nation’s leading health systems on strategic planning and digital transformation, supporting states in designing and implementing telehealth coverage and reimbursement policies, counseling emerging companies on go-to-market and business model strategies, advising a range of stakeholders on digital health policy issues, and partnering with foundations and nonprofit organizations to advance their impact.